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ABSTRACT
Neisseria meningitidis serogroup A accounted for 95% of cases of meningococcal disease in China during
the last century. To understand the circulation of these organisms in China over a 50-year period, 275
serogroup A meningococcal isolates collected between 1956 and 2005 were characterised by multilocus
sequence typing (MLST) and PorA typing. In total, 44 sequence types (STs), belonging to five
hyperinvasive lineages, and ten singletons were identified in this collection. The ST-5 complex and the
ST-1 complex represented 52.8% (86 ⁄ 163) and 44.2% (72 ⁄ 163), respectively, of isolates from cases
of infection and, overall, 93.1% (256 ⁄ 275) of all isolates. Three prevalent clones (ST-5, P1.5-2,10; ST-3,
P1.7-1,10; and ST-5, P1.20,9) were involved in four national epidemics in 1959, 1967, 1977 and 1984. ST-5
was replaced by ST-7 in the late 1980s, such that ST-7 isolates with P1.20,9 represented >86% of isolates
from cases of infection after 2000. The data also revealed that the collection contained 19 PorA VR types,
of which P1.7-1,10 and P1.20,9 were the predominant types in the ST-1 and ST-5 common lineages,
respectively. Three other hyperinvasive lineages (ST-11 complex, ST-32 complex and ST-4821 complex)
were isolated only from carriers. It was concluded that serogroup A meningococci of the ST-5 complex
and the ST-1 complex were responsible for most cases of meningococcal disease in China during the past
50 years.
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INTRODUCTION
Bacterial meningitis caused by Neisseria meningit-
idis is a serious threat to global health, accounting
for c. 100 000 cases worldwide each year, despite
the existence of partially effective vaccines [1]. It
is now known that >90% of cases of invasive
disease are caused by five of 13 serogroups of
N. meningitidis, and that the distribution of these
serogroups differs among geographical regions
[2]. Thus, serogroup A strains are predominant
in Africa and Asia, whereas serogroups B, C,
W135 and Y predominate in Europe, Australia
and the Americas [3].
In the last century, serogroup A meningococci
were responsible for >95% of cases of meningo-
coccal disease in China, whereas serogroups
B and C caused only sporadic cases [4]. Several
pandemic waves and national epidemics were
associated with a single clonal group of sero-
group A meningococci, called subgroup III,
which is still circulating in Africa and Asia
[5–7]. The cyclic nature of epidemic meningitis,
with peaks every 8–10 years, and an annual
disease rate of up to 500 cases ⁄ 100 000 inhabit-
ants, resulted in several million cases of
meningococcal disease in China between 1950
and 1980. Following the initiation of a national
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immunisation campaign during the early 1980s,
the morbidity rate of meningococcal disease
declined to 0.2–1.0 ⁄ 100 000. Starting in 2003,
several outbreaks of serogroup C meningococcal
disease, associated with the emergence of a new
hyperinvasive lineage (ST-4821 complex), caused
an increase in the number of serogroup C cases
[8]. However, despite the emergence of sero-
group C meningococci, serogroup A meningo-
cocci have remained an important cause of
meningococcal disease in China throughout the
last half century.
In previous studies, epidemic clones of sero-
group A meningococci were identified on the
basis of genotypic characteristics, e.g., electropho-
retic types, restriction fragment-length polymor-
phism types and genoclouds [4,6]. Few data
concerning isolates from cases of infection
collected during the inter-pandemic periods or
the distribution of genotypes among isolates from
carriers are available. In the present study, 275
isolates of serogroup A meningococci collected in
China during the past 50 years were characterised
by multilocus sequence typing (MLST) and PorA
variable region (VR) typing. MLST is currently the
approach used most widely to catalogue genetic
variation among meningococci, and characterises
each isolate according to its sequence type (ST) [9].
This nucleotide sequence-based technique gives
unambiguous and highly portable results that
allow a high level of discrimination among iso-
lates. Meningococci form clusters of related STs,
referred to as clonal complexes, consisting of a
founder ST and its variants, while PorA VR typing
characterises the antigenic diversity of a surface-
exposed porin that is putatively under immune
selective pressure. The present study expands the
information available concerning isolates from
recent epidemics of serogroup A disease in
China, and is also the first clonal analysis of
isolates collected from carriers in China during the
periods between pandemics.
MATERIALS AND METHODS
Bacteria
A convenience sample of 275 serogroup A meningococcal
isolates obtained from cases or carriers in 26 provinces of
China between 1956 and 2005 was studied. Invasive cases (i.e.,
isolates obtained from normally sterile sites such as cerebro-
spinal fluid or blood) accounted for 163 (59%) of the isolates
collected during the 50-year period, which included four
national epidemics of serogroup A meningitis in 1959, 1967,
1977 and 1984. The second and the fourth Chinese epidemic
waves occurred at the same time as the first and second
pandemics [4,5]. Another 112 isolates were obtained from
healthy carriers during the same period.
MLST
Isolates were characterised by MLST as described previously
[9], with an ABI Prism 3730 automated sequencer (Applied
Biosystems, Warrington, UK) being used to separate the
labelled extension products. The data were assembled using
SeqMan II of the DNASTAR program. Alleles, STs and clonal
complexes were assigned by reference to the Neisseria MLST
database (http://pubmlst.org/neisseria).
PorA VR typing
Fragments of porA genes (1.2 kb) were amplified and
sequenced as described previously [10,11] from all except
two isolates. Isolates were assigned to particular families of the
VR1 and VR2 regions by reference to the PorA typing website
(http://www.neisseria.org/nm/typing/pora).
Clonal complex analysis
Assignment of isolates to a clonal complex was performed by
identifying a founder or central genotype with the BURST
algorithm, implemented in the computer programs START
and SPLITSTREE [12,13]. Relationships among STs were also
analysed using eBURST [14]. All of the programs used in this
study are available for electronic download (http://
mlst.zoo.ox.ac.uk; http://bibiserv.techfak.uni-bielefeld.de/splits;
http://evolgen.biol.metro-u.ac.jp/MEGA/).
RESULTS
STs and lineages found in the collection
There were 44 STs among the 275 isolates typed
by MLST, 35 of which were novel and represented
15% (40 ⁄ 275) of the collection (Table 1). The other
nine STs accounted for 85% (235 ⁄ 275) of isolates.
Three STs (ST-3, ST-5 and ST-7) accounted for
80.7% (222) of the total isolates.
Cluster analysis revealed that there were five
clonal complexes containing 34 of the STs present
in the collection (Table 1). The ST-1 and ST-5
complexes were the two most common com-
plexes, containing 93.1% (256 ⁄ 275) of the isolates.
The ST-1 complex contained 15 STs, with 11
single-locus variants (SLVs) and three double-
locus variants of ST-3, including 14 STs identified
for the first time in the present study. The most
common complex was the ST-5 complex, consist-
ing of two predominant STs (ST-5 and ST-7).
There were four SLVs of ST-5 and eight SLVs of
ST-7, with ST-7 being an SLV of ST-5 in the ST-5
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complex. Three complexes (ST-11 complex, ST-32
complex and ST-4821 complex) contained a total
of only five STs, accounting for 2.2% (6 ⁄ 275) of
the total isolates, all of which were from carriers.
Ten STs did not belong to any known clonal
complex and accounted for 4.7% (13 ⁄ 275) of the
isolates.
Among 163 isolates from cases of infection,
96.9% (158 ⁄ 163) belonged to either the ST-1
complex (nine STs) or the ST-5 complex (nine
STs); the remaining five isolates belonged to four
STs that were not in known complexes (Tables 1
and 2). The 112 isolates from healthy carriers were
slightly more diverse, belonging to five clonal
complexes and singletons, with 98 (87.5%) iso-
lates belonging to either the ST-1 complex (seven
STs) or the ST-5 complex (nine STs), and 14
isolates belonging to other clonal complexes
Table 1. Characteristics of serogroup A meningococci isolated in China, 1956–2005
Lineage ST porA VR type No. of isolates Date (n)
ST-1 complex ⁄ subgroup I ⁄ II ST-3 P1.7-1,10 Patient (57) 1972 (1); 1973 (5); 1974 (9); 1976 (1); 1977 (1); 1978 (4); 1979 (21); 1980 (5); 1982 (5);
1984 (1); 1985 (3); 2004 (1)
Carrier (24) 1974 (2); 1978 (1); 1979 (9); 1980 (1); 1982 (3); 1984 (5);1985 (1);1987 (1); 1991 (1)
P1.7-1,10-3 Patient (2) 1978 (1); 1982 (1)
P1.7-3,10 Patient (2) 1976 (2)
Carrier (8) 1979 (6);1985 (1); 1986 (1)
P1.7-4,10 Patient (2) 1985 (1); 1986 (1)
P1.12-6,4-1 Patient (1) 1984 (1)
ST-4991 p1.18-7,34-2 Carrier (1) 1979 (1)
ST-5080 P1.7-1,10 Carrier (1) 1978 (1)
ST-5239 P1.7-1,10 Patient (1) 1974 (1)
ST-5240 P1.7-1,10 Patient (1) 1974 (1)
ST-5241 P1.7-1,10 Carrier (1) 1978 (1)
ST-5242 P1.7-3,10 Patient (1) 1979 (1)
ST-5243 P1.7-1,10 Patient (1) 1974 (1)
ST-5245 P1.7-4,10 Patient (1) 1978 (1)
ST-5249 P1.7-1,10 Patient (1) 1980 (1)
ST-5250 P1.7-1,10 Patient (1) 1980 (1)
ST-5254 P1.7-1,10 Carrier (1) 1984 (1)
ST-5255 P1.7-1,10 Carrier (1) 1977 (1)
ST-5258 P1.7-1,10 Patient (1) 1985 (1)
ST-5464 P1.7-1,10 Carrier (1) 1984 (1)
ST-5 complex ⁄ subgroup III ST-5 P1.5-2,10 Patient (3) 1956 (1); 1963 (1); 1973 (1)
Carrier (4) 1963 (4)
P1.20,9 Patient (36) 1966 (1); 1977 (1); 1978 (1); 1983 (2); 1984 (10); 1985 (11); 1986 (4); 1987 (4);
1988 (1); 1996 (1)
Carrier (29) 1966 (2); 1980 (4); 1982 (1); 1984 (11); 1985 (6); 1986 (1); 1987 (3); 2000 (1)
ST-7 P1.20,9 Patient (32) 1984 (2); 1987 (2); 1991 (1); 1994 (2); 1995 (3); 2000 (1); 2004 (2);2005 (19)
Carrier (17) 1984 (3); 1986 (1); 2000 (1); 2005 (12)
P1.20-1,9 Patient (1) 2005 (1)
P1.20-3,9 Patient (3) 2002 (3)
Carrier (1) 1991 (1);
ST-203 P1.20,9 Patient (1) 1984 (1)
ST-4898 P1.20,9 Carrier (1) 2004 (1)
ST-5079 P1.5-2,10 Carrier (3) 1963 (3)
ST-5082 P1.20,9 Patient (2) 2005 (2)
ST-5083 P1.20,9 Patient (1) 2005 (1)
ST-5084 P1.20,9 Carrier (1) 2005 (1)
ST-5114 P1.20-1,9 Carrier (1) 2005 (1)
ST-5246 P1.20,9 Patient (2) 1983 (1); 1985 (1)
ST-5247 P1.20,9 Patient (1) 1985 (1)
ST-5251 P1.20,9 Patient (3) 1966 (1); 1975 (1); 1984 (1)
Carrier (1) 1987 (1)
ST-5256 P1.20,9 Patient (1) 1985 (1)
Carrier (1) 1984 (1)
ST-5466 NA Carrier (1) 2005 (1)
ST-11 ⁄ ET-37 complex ST-11 P1.5-1,2-2 Carrier (2) 1984 (2)
ST-32 ⁄ET-5 complex ST-1784 P1.7,16 Carrier (1) 1979 (1)
ST-4821 complex ST-3200 P1.20,23 Carrier (1) 2005 (1)
ST-4821 P1.20, 23-7 Carrier (1) 2005 (1)
ST-4897 P1.21-2,28 Carrier (1) 2005 (1)
ST-59 ST-59 P1.7-1,10 Patient (2) 1980 (1); 1982 (1)
Carrier (2) 1980 (2)
ST-685 ST-685 P1.5-1,2-2 Carrier (1) 1992 (1)
ST-5113 ST-5113 P1.21,23-10 Carrier (1) 2005 (1)
ST-5244 ST-5244 P1.7-1,10 Patient (1) 1974 (1)
ST-5248 ST-5248 P1.19,13 Carrier (1) 1986 (1)
ST-5252 ST-5252 P1.22,14-6 Patient (1) 1977 (1)
ST-5253 ST-5253 P1.12-13,13-20 Patient (1) 1984 (1)
ST-5257 ST-5257 NA Carrier (1) 1978 (1)
ST-5294 ST-5294 P1.12-6,4-1 Carrier (1) 1985 (1)
ST-5465 ST-5465 P1.20,9 Carrier (1) 1993 (1)
ST, sequence type; NA, not amplified.
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(ST-11, ST-32, and ST-4821 complexes) and
seven singletons (eight isolates). There were 22
STs and 28 STs represented among isolates
from cases and carriers, respectively; six STs
(ST-3, ST-5, ST-7, ST-59, ST-5251 and ST-5256)
were seen among isolates from both cases and
carriers.
Diversity of housekeeping genes
The total number of alleles at each locus for the
275 isolates ranged from five for adk to 16 for aroE.
The total number of alleles at other loci included
12 for abcZ, 15 for fumC and pgm, nine for gdh, and
14 for pdhC. Of these 86 alleles, 15 were identified
for the first time in this study: four (abcZ-331, abcZ-
333, fumC-368, gdh-379) were present in SLVs of
ST-3; three (aroE-382, aroE-383, pdhC-354) were
present in SLVs of ST-5; and eight (abcZ-338, aroE-
402, fumC-361, fumC-369, pdhC-362, pdhC-370, pgm-
358 pgm-366) were present in singletons.
To illustrate the diversity of alleles within the
two most common lineages, Fig. 1 shows an
analysis of the alleles at each locus for the ST-5
complex. The generation of variants of ST-1 was
accounted for by 16 variant alleles at five loci (three
abcZ, three adk, two aroE, four fumC, two gdh and
two pdh variants). All three double-locus variants
of ST-1 had variant alleles in fumC. For the ST-5
complex, 12 variant alleleswere detected at six loci,
two of which contained more than half of these
variants (four aroE and three pgm alleles; Fig. 1).
PorA VR types among isolates
Sequencing and PorA VR analysis of 273 isolates
revealed 19 different PorA VR types (Table 1).
The ST-1 complex contained six types, with
P1.7-1,10 being the most prevalent, representing
83.6% (92 ⁄ 110) of the isolates in the ST-1 complex.
Three variants of this family (P1.7-4,10, P1.7-1,10-
3 and P1.7-3,10) accounted for all but two of the
remaining isolates in the ST-1 complex. P1.12-6,4-
1 and P1.18-7,34-2 were each represented in the
ST-1 complex by a single isolate. Only four types
(P1.5-2,10, P1.20,9, P1.20-1,9 and P1.20-3,9) were
found among the 146 isolates in the ST-5 complex,
of which P1.20,9 was the most prevalent type,
representing 89.4% (129 ⁄ 146) of the isolates in
this complex. There was only slightly more
diversity among isolates from carriers (15 PorA
types among 112 isolates, or one type for every 7.5
isolates) than among isolates from cases of inva-
sive disease (11 PorA types among 163 isolates, or
one type for every 14.8 isolates; p 0.06) (Table 1).
The remaining isolates were present as only
one or two isolates ⁄ subtype. Only three PorA
types that were seen in the ST-1 or ST-5 com-
plexes were also present among the remaining
isolates. The porA gene of two isolates (ST-5257
and ST-5466) could not be amplified.
Invasive clones
Most of the cases of invasive disease were caused
by only three clones, with ST-3, P1.7-1,10 of the
ST-1 complex, ST-5, P1.20,9 of the ST-5 complex,
and ST-7, P1.20,9 of the ST-5 complex accounting
for 76.7% (125 ⁄ 163) of all cases. ST-7 is an SLV of
ST-5. These three clones also accounted for a
significant proportion (62.5%) of all carrier iso-
lates (p 0.01).
eBURST cluster analysis
Fig. 2 summarises the results of the eBURST
cluster analysis of the ST-1 complex. Based on
the data contained in the MLST database, ST-3
Table 2. Temporal distribution of
sequence types (STs) and lineages
found among isolates from cases of
infection (bold figures indicate that a
high frequency of a particular ST
was detected compared with the
other periods)
Perioda
ST-1 complex ST-5 complex
Others
No. of
isolatesST-3 Variants ST-5 ST-7 Variants
Before 1965 0 0 2 (100) 0 0 0 2
1965–1970
(first pandemic)
0 0 1 (50) 0 1 (50) 0 2
1971–1981 49 (76.6) 8 (12.5) 3 (4.7) 0 1 (1.5) 3 (4.7) 64
1982–1988
(second pandemic)
13 (22.4) 1 (1.7) 32 (55.2) 4 (6.9) 6 (10.3) 2 (3.5) 58
1989–1992 0 0 0 1 0 0 1
1993–2000
(third pandemic)
0 0 1 (14.3) 6 (85.7) 0 0 7
After 2000 1 (3.4) 0 0 25 (86.2) 3 (10.4) 0 29
Total 63 9 39 36 11 5 163
aThe periods shown are those listed by Zhu et al. [6].
Values in parentheses are percentages.
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and its variants seem to have emerged in China,
whereas the other STs belonging to this complex
were more closely related and were isolated
elsewhere.
DISCUSSION
Molecular characterisation of meningococcal
isolates is crucial for analysis of the bacterial
factors that modulate the epidemic behaviour of
N. meningitidis. Molecular typing methods based
on DNA sequencing data, e.g., MLST and PorA
VR typing, are currently the standard methods for
epidemiological analysis of meningococci, as they
allow a high level of discrimination among
isolates. At the time of the present study, the
MLST database (http://pubmlst.org/neisseria)
contained >6000 genotypes, represented by
isolates from global sources. Analysis of PorA
VR types shows the antigenic diversity of N. men-
ingitidis and helps to elucidate the molecular
character of the cell surface antigens, reflecting
the influence of host immunity on population
structure [15].
The present study investigated the distribution
and changes in the lineages of serogroup A
meningococci prevalent in China during the last
50 years. The study revealed that two common
lineages prevailed in China between 1956 and
2005. One common lineage of the ST-5 complex
has persisted continuously in China for at least
the last 50 years. As only four isolates from before
1971 were available for subtyping, it is difficult to
conclude that this was the predominant genotype
isolated from cases of invasive disease at that
time, even though all four isolates belonged to the
ST-5 complex. In contrast, isolates belonging to
ST-3 and variants of the ST-1 complex predomi-
nated during the inter-pandemic period between
1971 and 1981. The circulation of this lineage
continued in a few provinces (Guangdong, Guan-
gxi, Guizhou, Jiangxi) in the southeast of China
during the early 1980s, but few isolates belonging
to the ST-1 complex have been recognised since
1989.
The ST-5 complex ⁄ subgroup III appears to
have been an important lineage in China for
50 years, and still remains the predominant line-
age of serogroup A. Two common STs of this
hyperinvasive lineage were associated with a
series of outbreaks of serogroup A disease,
including the outbreaks during 1984 and 1994
Fig. 1. Diversity of isolates from
China belonging to the ST-5 com-
plex.
ST-3
ST-2
ST-1
ST-77
ST-57
China
East Europe
West Europe
America
Worldwide
Fig. 2. eBURST analysis of the ST-1 complex showing the
geographical distribution of different sequence types (STs)
belonging to this complex.
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(Table 2). ST-5 was probably the predominant
genotype before 1970 and during the 1980s,
causing >50% of cases of infection during these
two periods, which included three countrywide
epidemics in 1959, 1967 and 1984 [5]. However,
although ST-5 isolates predominated during these
three epidemics, the PorA VR types varied in each
epidemic cycle. P1.5-2,10 was isolated mainly
before 1973, and was represented by seven of ten
ST-5 isolates collected during 1956–1973. Another
common PorA VR type, P1.20,9, was prevalent
after 1977, but seems to have first emerged
around 1966. ST-5, P1.20,9 isolates were seen in
two epidemic waves during the 1960s and 1980s.
ST-7 strains with P1.20.9 emerged as the most
common genotype after 1989, representing the
majority of isolates from cases of infection. Of 36
disease-associated isolates after 1989, 32 (89%)
belonged to this ST ⁄PorA combination. As shown
in Table 2, the increase in the proportion of ST-7
isolates occurred after 1989, and ST-7 seems to
have become the predominant genotype in China
during the 1990s. The emergence of ST-7 in the
African meningitis belt also occurred during this
period [7,16].
Serogroup A meningococci belonging to the
ST-1 complex ⁄ subgroup I ⁄ II have circulated
worldwide [17]. The first subgroup I strain recog-
nised was isolated in the UK in 1941. At the
beginning of the 1960s, this lineage was identified
in North Africa and in countries of the African
meningitis belt, and subsequently caused out-
breaks of disease in the Americas (Brazil, USA
and Canada), Europe and Australia. It remained
the predominant serogroup A clone in South
Africa in the late 1990s [18]. The present data
revealed that 15 members of the ST-1 complex,
including ST-3, the common Chinese epidemic ST
and its variants, had emerged in China, but that
they were slightly different from the prevalent
genotypes seen in other countries. An eBURST
cluster analysis (Fig. 2) suggested that the ST-3
cluster appeared to have emerged in China, and
that there were closer relationships among other
members of this complex that occurred elsewhere.
Isolates belonging to these STs have similar types
of outer-membrane proteins (PorA, FetA) [19]; the
most common combination is P1.5-2,10 ⁄ F5-1,
whereas P1.7-1,10 ⁄ F5-5 was seen in some ST-3
isolates.
The ST-1 complex was prevalent in countries
neighbouring China, e.g., India, The Philippines
and Pakistan, during the 1960s, but there is no
evidence that these strains, other than ST-3,
spread to China [19]. ST-3 was the predominant
ST, representing up to 77% of isolates from cases
of infection between 1971 and 1981 in China. It is
striking that fewer ST-3 cluster isolates were
obtained before 1970 and after 1988, and that the
ST-3 cluster has nearly disappeared today. When
compared to the long-term prevalence of the ST-5
complex, the emergence and disappearance of the
ST-3 cluster was only a short episode during the
natural history of serogroup A meningococci in
China in the last 50 years. P1.7-1,10 was the
commonest PorA VR type found among the ST-
3 isolates predominant in China since the 1970s,
accounting for 83.6% (92 ⁄ 110) of the ST-1 com-
plex ⁄ subgroup isolates. Immune selection against
P1.7-1,10 may have caused the ST-3 cluster to
disappear from the population.
MLST and PorA VR typing have not only
provided a wealth of information about the
serogroup A meningococci prevalent in China,
but have also revealed the extent of microevolu-
tion within the meningococcal population.
Among the isolates investigated, 21 (75%) of 28
variants of the prevalent clone were generated by
replacing alleles of the prevalent clone at one or
two loci, whereas the others represented the
emergence of novel alleles. Furthermore, allelic
replacement often occurred among variants of
disease isolates, whereas novel alleles emerged in
those variants represented by isolates from carri-
ers. This suggests that different mechanisms are
involved in the evolution of disease-associated
and carrier strains, although these collections
represented different combinations of polymor-
phisms from a common gene pool [20].
In conclusion, the present study investigated
isolates from both cases of disease and healthy
carriers, and revealed the general features of
serogroup A meningococci that have been
prevalent in China in the past 50 years. The
study also revealed that three clones (ST-5 with
P1.5-2,10, ST-3 with P1.7-1,10, and ST-5 with
P1.20,9) were the cause of the four previous
epidemics in China, and that ST-7 with P1.20,9 is
the representative clone of serogroup A men-
ingococci that is currently found in China. In
addition, the molecular characterisation of
meningococcal isolates from healthy carriers
provided useful information about the evolution
of these organisms.
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